Cheap drugs pay for Aurobindo Pharma as USFDA approvals surge supriya kashyap kashyap28 Sept 2017 10:16 AM ISTMumbai: While India’s largest pharmaceutical companies have seen drug approvals in the US slow overall, their research and development (R&D)...
Sanofi , Innovation Health Announces Pilot Program to Improve Care Delivery inType 2 Diabetes supriya kashyap kashyap28 Sept 2017 9:16 AM ISTFalls Church: Innovation Health, a unique partnership between two industry leaders, Inova and Aetna, and Sanofi, a global healthcare leader, announced...
OPPI elects A Vaidheesh as new president Ruby Khatun Khatun27 Sept 2017 12:44 PM ISTNew Delhi: The Organisation of Pharmaceutical Producers of India (OPPI) has unanimously elected A Vaidheesh, vice president, South Asia & Managing...
Lupin gets USFDA nod for generic version of Clobex lotion Ruby Khatun Khatun27 Sept 2017 12:43 PM ISTNew Delhi: Drug maker Lupin said it has received approval from the US health regulator to market anti-inflammatory Clobetasol Propionate lotion in the...
Patanjali's Balkrishna in Hurun India rich list Ruby Khatun Khatun27 Sept 2017 12:43 PM ISTMUMBAI: Acharya Balkrishna, the head of yoga expert Baba Ramdev-run FMCG company Patanjali and Radhakishan Damani of D-Mart have found their place...
Kyocera to expand medical product development supriya kashyap kashyap27 Sept 2017 9:16 AM ISTTokyo: Kyocera Corporation announced plans to expand operations at its new Medical Development Center which opened in Japan's Shiga Prefecture at the...
Zydus Cadila gets USFDA nod to sell BP lowering drug Ruby Khatun Khatun26 Sept 2017 10:49 AM ISTNew Delhi: Cadila Healthcare on Saturday said its group firm Zydus Cadila has received the final approval from the US health regulator to market blood...
Novartis India board clears share buyback worth Rs 231 crore Ruby Khatun Khatun26 Sept 2017 10:34 AM ISTNew Delhi: Drug firm Novartis India on Monday said its board has approved buyback of up to 34.5 lakh shares, accounting for about 12.26 percent of the...
Perrigo gets FDA final approval for generic version of Exalgo® 32mg extended release tablets Ruby Khatun Khatun26 Sept 2017 9:51 AM ISTDUBLIN: Perrigo Company plc announced it has received final approval from the U.S. Food and Drug Administration (FDA) for its AB-rated Abbreviated New...
AbbVie, Bristol-Myers announce clinical research collaboration to evaluate a therapeutic regimen in advanced solid tumors Ruby Khatun Khatun26 Sept 2017 9:26 AM ISTNORTH CHICAGO, Ill. and NEW YORK: AbbVie and Bristol-Myers Squibb Company announced a clinical trial collaboration to evaluate the combination of...
Glenmark expects generics to drive growth over next 3 yrs Ruby Khatun Khatun25 Sept 2017 10:37 AM ISTMumbai: Pharma firm Glenmark Pharmaceuticals has said its pipeline of specialty and innovative products over the next three to four years is expected...
Roche cancer immunotherapy Tecentriq wins EU approval Ruby Khatun Khatun25 Sept 2017 10:17 AM ISTZURICH: Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.The...
